Remote Temperature Monitoring of Patients At Risk for Developing Fever

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAION Biosystems

About this trial

The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are:

* does remote temperature monitoring reduce the number of days spent inpatient * what out-of-pocket cost can a patient expect to incur for participating in remote temperature monitoring * the number of billable CPT codes that will be generated by providing remote temperature monitoring

Researchers will compare compliant and non-compliant patients to assess if compliance with remote temperature monitoring is associated with a decrease in the number of days spent inpatient.

Patients will

* wear the thermometer for the duration of their participation in the study * have their temperature monitored continuously * receive alerts on their phone when their temperature exceeds a threshold for a sustained duration, configurable by their physician * respond to texts or calls from remote monitors when an alert is triggered

Eligibility criteria

Qualifiers

Subject is at risk of a fever post discharge.

Subject is ≥ 18 years or older.

Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device.

Subject is willing to install the TempShield app on his/her phone.

Disqualifiers

Unable to provide informed consent

Subjects with a history of Medical Adhesive-Related Skin Injury (MARSI)

Subjects with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.)

Non-English speakers: The mobile application is only currently available in English. Future development will include other languages.

Trial design

Treatments tested in this trial

  • Remote Patient Monitoring

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators

AION Biosystems

Lead sponsor

Ellis Medicine

Collaborator